Knee Osteoarthritis Treatment Options
Knee osteoarthritis is one of the most common causes of knee pain, stiffness, and reduced mobility in adults. It occurs when the smooth, protective cartilage that lines the ends of the bones within the joint gradually wears away. As this cushioning decreases, the knee becomes inflamed, painful, and less able to move comfortably during daily activities. Many people describe knee osteoarthritis as a slow, progressive process that begins with mild soreness or stiffness and eventually becomes more limiting over time. Understanding what knee osteoarthritis is, how it develops, and what treatment options are available is the first step toward regaining comfort, mobility, and quality of life.
Yes—knee bracing is a simple, noninvasive way to reduce pain by shifting weight away from the most arthritic part of the knee. This is known as off-loading the joint.
Options include:
- Medial off-loading braces for inner (medial) knee arthritis
- Lateral off-loading braces for outer (lateral) knee arthritis
- Patellofemoral braces for arthritis behind the kneecap
A properly fitted brace can improve walking, reduce pain during activity, and delay the need for more invasive treatments.
Arthroscopic surgery (a minimally invasive “clean-up” procedure) is not typically used for arthritis alone. However, it may be helpful when osteoarthritis is combined with certain mechanical problems such as:
- A torn or unstable meniscus
- Loose cartilage fragments
- Joint catching, locking, or instability
- Synovitis (inflammation of the joint lining)
In these cases, arthroscopy can reduce symptoms and improve joint function, even if it does not reverse underlying cartilage wear.
An osteotomy is a procedure that realigns the bones of the leg to shift weight away from the arthritic portion of the knee. It is most appropriate for younger or active patients who have arthritis on one side of the knee and an alignment issue such as bow-legs (varus) or knock-knees (valgus).
Types of osteotomies include:
- High tibial osteotomy (HTO): Shifts weight away from the medial compartment
- Distal femoral osteotomy (DFO): Used for lateral compartment arthritis
- Tibial tubercle osteotomy: Used when arthritis affects the kneecap (patellofemoral compartment)
Osteotomy preserves the patient’s natural knee joint and can delay the need for knee replacement for many years.
The MISHA implant is a newer, joint-preserving treatment designed for patients with medial (inner) knee osteoarthritis who are too young or active for knee replacement but need more relief than injections or therapy can provide.
MISHA works by:
- Absorbing shock during walking and activity
- Reducing load on the inner part of the knee
- Improving comfort with daily movement
- Allowing full weight-bearing soon after surgery
Unlike knee replacement, MISHA does not remove bone or cartilage. It is an excellent option for adults in their 40s–60s who want to maintain an active lifestyle while delaying joint replacement.
A partial knee replacement (also called unicompartmental knee arthroplasty) is used when arthritis affects only one part of the knee—either medial, lateral, or patellofemoral.
Advantages include:
- Smaller incision
- Faster recovery
- More natural knee motion
- Less blood loss and bone removal
- High satisfaction rates in properly selected patients
Because only one part of the joint is replaced, a partial knee replacement preserves healthy cartilage and ligaments.
For patients with severe, multi-compartment knee osteoarthritis, total knee replacement (TKR) is often the most effective long-term solution. Modern total knee replacements are designed to relieve pain, restore function, and allow patients to return to activities they enjoy.
TKR is recommended when:
- Non-surgical options no longer provide relief
- Pain limits daily life or sleep
- The knee feels unstable or increasingly stiff
- X-rays show severe “bone-on-bone” changes
Most patients experience dramatic pain relief and improved mobility within a few months of surgery.
When considering advanced options for knee osteoarthritis, many patients ask about stem cell therapy—specifically “mesenchymal stem cells” (MSCs) that have the potential to reduce inflammation, promote healing, and possibly aid cartilage regeneration. In the United States, however, the landscape is complex: true MSC therapies approved by the Food and Drug Administration (FDA) for knee arthritis do not yet exist outside of regulated clinical trials. Autologous bone marrow aspirate concentrate (BMAC) and adipose-derived cell concentrates are often marketed as stem cell treatments for knee OA, but many of these involve “minimally manipulated” cells and are not classified as MSC drugs under current rules. Clinics using allogeneic (donor-derived) MSCs from umbilical cord or fat tissue for knee OA are largely operating under research protocols or outside formal approval.
Practically speaking, if you are exploring MSC therapy for knee OA, here are your options:
- Autologous BMAC / bone marrow-derived MSCs: A physician harvests bone marrow (typically from the hip), process it to concentrate regenerative cells, and injects it into the knee joint.
- Autologous adipose-derived cell concentrate: Fat is harvested (often via liposuction), processed to isolate cell fractions which may include MSCs, and then injected into the knee. These also may fall under “minimally manipulated” definitions in some states but lack FDA-approved MSC labeling for OA.
- Allogeneic donor MSCs (such as umbilical cord or placenta derived): These have significant regulatory hurdles in the US because donor-derived cells are considered drugs and must go through FDA approval. Some clinics in other countries offer them, but in the US they are mostly available only via registered clinical trials.
While studies have shown that stem cell injections improve symptoms of knee osteoarthritis (just as much as other injections like corticosteroids), there is no scientific evidence to suggest that stem cell injections regrow cartilage or reverse osteoarthritis.
In summary, MSC therapy for knee osteoarthritis is an experimental option in the United States. If you are considering it, do so with full awareness of the regulatory status, clinical evidence, and cost/benefit comparison to other established treatments.
Knee osteoarthritis is a common condition that can significantly affect your comfort, mobility, and overall quality of life. The good news is that there are many effective treatments—from physical therapy and bracing to injections, MISHA implants, osteotomy, and knee replacement. With the right combination of nonsurgical and surgical options, most patients can reduce pain, stay active, and maintain the lifestyle they enjoy.
If you are struggling with knee pain or stiffness, or if your symptoms are limiting your work, exercise, or daily activity, please contact Dr. José Vega’s office in Cleveland to schedule a consultation. Together, we can evaluate your knee osteoarthritis, review your goals, and develop a personalized treatment plan to help you feel and move your best.
References
- Bharadwaj UU, Lynch JA, Joseph GB, et al. Intra-articular Knee Injections and Progression of Knee Osteoarthritis: Data from the Osteoarthritis Initiative. Radiology. 2025;315(2):e233081.
- Ciapini G, Simonettii M, Giuntoli M, et al. Is the Combination of Platelet-Rich Plasma and Hyaluronic Acid the Best Injective Treatment for Grade II-III Knee Osteoarthritis? A Prospective Study. Adv Orthop. 2023;2023:1868943.
- Deyle GD, Allen CS, Allison SC, et al. Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee. N Engl J Med. 2020;382(15):1420-1429.
- Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A. PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. Cartilage. 2021;13(1_suppl):364S-375S.
- Gomoll AH, Diduch DR, Flanigan DC, et al. An implantable shock absorber yields an 85% survival-from-arthroplasty rate through 5 years in working-age patients with medial compartment knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2023;31(8):3307-3315.
- Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149-162.
- Mautner K, Gottschalk M, Boden SD, et al. Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med. 2023;29(12):3120-3126.
At a Glance
Dr. Jose Vega
- Board-certified orthopedic surgeon
- Fellowship-trained sports medicine specialist
- Author of industry leading peer reviewed publications
- Learn more